Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00589888 · ClinicalTrials.gov registry record · NA
FFA-Induced Hypertension and Endothelial Dysfunction
A NA study, sponsored by Emory University.
- Completed
- Registry status
- NA
- Development phase
- 13
- Enrollment target
NCT00589888 is a NA study that has completed, run by Emory University. The registered enrollment target is 13 participants.
The verdict
NCT00589888, a NA study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- NA
- Development phase
- 13 participants
- Enrollment target
Study Summary
The study is a prospective open label study to examine the effects of oral and intravenous fat load on blood pressure, endothelial function, sympathetic activity, and oxidative stress in obese healthy subjects. Subjects will receive either 8-hour of intravenous or oral fat loads in either low or high doses or normal saline in random order. Blood samples are drawn and vitals are measured before and after the infusions. Endothelial function and plasma glucose and lipid levels are measured to study the effects.
Interventions
- DRUG Normal Saline
- DRUG Intralipid 20% @ 20cc/hour
- DRUG Intralipid 20%@ 40cc/hour
- DIETARY_SUPPLEMENT 32-gram oral fat load
- DIETARY_SUPPLEMENT 64-gram oral fat load
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2006-08 |
| Est. Completion | 2008-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00589888
The ClinicalTrials.gov registry entry for NCT00589888 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Normal Saline is the first listed.
NCT00589888 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00589888 about?
NCT00589888 is a clinical study titled "FFA-Induced Hypertension and Endothelial Dysfunction". The study is a prospective open label study to examine the effects of oral and intravenous fat load on blood pressure, endothelial function, sympathetic activity, and oxidative stress in obese healthy subjects. Subjects will receive either 8-hour of intravenous or oral fat loads in either low or hig...
What is the current status of trial NCT00589888?
This trial is currently completed. It is a NA study. The enrollment target is 13 participants. The study started on 2006-08. Estimated completion is 2008-08.
What interventions are being tested in trial NCT00589888?
The interventions under investigation include: Normal Saline (DRUG), Intralipid 20% @ 20cc/hour (DRUG), Intralipid 20%@ 40cc/hour (DRUG), 32-gram oral fat load (DIETARY_SUPPLEMENT), 64-gram oral fat load (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00589888?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.